MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC
Clinical trial NCT04633564 · COMPLETED
Trial details
- NCT number
- NCT04633564
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-21
- Primary completion
- 2019-06-05
- Enrollment
- 671
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.